Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 8: Combining Immunotherapies, Immune Modulators, and Targeted Therapies: Regulatory Opportunities and Challenges

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Introductions
F. Stephen Hodi
Dana-Farber Cancer Inst., Boston, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
Regulatory Perspectives and Updates
Ke Liu
U.S. Food and Drug Administration, Rockville, MD, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
Engaging an adaptive immune response in cancer
Michael A. Postow
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
A pharmaceutical development point of view
Renzo Canetta
Bristol-Myers Squibb Co., Wallingford, CT, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
Melanoma Research Alliance: Investing in innovation
Louise M. Perkins
Melanoma Research Alliance, Washington, DC, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
Panel Discussion
F. Stephen Hodi
Dana-Farber Cancer Inst., Boston, MA, United States
Ke Liu
U.S. Food and Drug Administration, Rockville, MD, United States
Michael A. Postow
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
Renzo Canetta
Bristol-Myers Squibb Co., Wallingford, CT, United States
Louise M. Perkins
Melanoma Research Alliance, Washington, DC, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
Panel: Audience Q & A
F. Stephen Hodi
Dana-Farber Cancer Inst., Boston, MA, United States
Ke Liu
U.S. Food and Drug Administration, Rockville, MD, United States
Michael A. Postow
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
Renzo Canetta
Bristol-Myers Squibb Co., Wallingford, CT, United States
Louise M. Perkins
Melanoma Research Alliance, Washington, DC, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 23, 2013 10:30 AM-12:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7